Bacteriophage Therapy Trial
Phase 1
30
about 1.9 years
18+
2 sites in MO, TX
About this study
This trial is testing the safety of a phage treatment in adults with spinal cord injuries and bacteriuria. Participants will receive either phage therapy or a placebo for 696 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take Phage Therapy
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: To evaluate the safety and tolerability of phage therapy in adults ≥18 years of age with spinal cord injury (SCI) and bacteriuria with Escherichia coli (E. coli)
Secondary: To evaluate of the pharmacodynamics (PD) of investigational phage therapy, To evaluate the pharmacokinetics (PK) of investigational phage therapy
Neurology